SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-174472
Filing Date
2014-05-01
Accepted
2014-05-01 07:11:34
Documents
3
Period of Report
2014-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d719790d8k.htm 8-K 17217
2 EX-99.1 d719790dex991.htm EX-99.1 41349
3 EX-99.2 d719790dex992.htm EX-99.2 16909
  Complete submission text file 0001193125-14-174472.txt   76663
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 14801931
SIC: 2834 Pharmaceutical Preparations